Author

A. Altendorf-Hofmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

M. F. Orth· 2 shared T. G. P. Grunewald· 2 shared T. Kirchner· 2 shared A. Marchetto· 1 shared E. Butt· 1 shared E. Kampmann· 1 shared E. Noessner· 1 shared F. Cidre-Aranaz· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. F. Orth

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 8, 2019

Expression patterns of PD-L1 and PD-1 provide rationales for immune checkpoint inhibition in soft tissue sarcomas

M. F. Orth, V. L. Buecklein, E. Kampmann…·T. Knoesel

This study examines PD-L1 and PD-1 expression in soft tissue sarcomas and finds associations with TILs and poor clinical outcomes, supporting immune checkpoint inhibition in PD-L1-positive cases.

DOI 10.1101/569418

humanbulk RNA-seq

𝕏 PostBluesky

PathologybioRxivMar 31, 2018

Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma

M. F. Orth, J. S. Gerke, T. Knosel…·T. G. P. Grunewald

This study identifies AMPD2 as a prognostic biomarker for undifferentiated pleomorphic sarcoma using transcriptome analysis, immunohistochemistry, and functional assays.

DOI 10.1002/ijc.31903

humanbulk RNA-seq

𝕏 PostBluesky